830
Participants
Start Date
December 17, 2021
Primary Completion Date
February 25, 2030
Study Completion Date
February 25, 2030
MK-1084
Oral dose
Pembrolizumab
Intravenous infusion of 200 mg
carboplatin
Per label
pemetrexed
Per label
cetuximab
Per label
oxaliplatin
Per label
leucovorin
Per label
5-fluorouracil
Per label
RECRUITING
National Cheng Kung University Hospital ( Site 0444), Tainan City
RECRUITING
Chris O'Brien Lifehouse ( Site 0002), Camperdown
RECRUITING
Westmead Hospital ( Site 0006), Westmead
RECRUITING
Liverpool Hospital-Medical Oncology ( Site 0001), Liverpool
RECRUITING
Monash Health-Oncology Research ( Site 0003), Clayton
RECRUITING
Odense Universitetshospital-Department of oncology ( Site 0421), Odense
RECRUITING
Ospedale Regionale Bellinzona e Valli ( Site 0220), Bellinzona
RECRUITING
Ankara City Hospital-oncology ( Site 0233), Ankara
COMPLETED
New Zealand Clinical Research (Christchurch) ( Site 0004), Christchurch
RECRUITING
Cantonal Hospital St.Gallen ( Site 0224), Sankt Gallen
RECRUITING
National Taiwan University Hospital-Oncology ( Site 0443), Taipei
COMPLETED
Laura and Isaac Perlmutter Cancer Center ( Site 0270), New York
RECRUITING
MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 0254), Cherkasy
RECRUITING
Humanitas ( Site 0113), Rozzano
RECRUITING
NEXT Virginia ( Site 0271), Fairfax
RECRUITING
Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 0255), Kropyvnytskyi
RECRUITING
Clinica Universidad de Navarra ( Site 0213), Madrid
RECRUITING
Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD ( Site 0211), Madrid
COMPLETED
Rivne Regional Clinical Hospital ( Site 0257), Rivne
RECRUITING
ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 0259), Rivne
RECRUITING
Moffitt Cancer Center ( Site 0261), Tampa
COMPLETED
Ege University Medicine of Faculty ( Site 0231), Bornova
COMPLETED
Erciyes University ( Site 0232), Talas
RECRUITING
Hospital of Lithuanian University of Health Sciences Kauno klinikos ( Site 0121), Kaunas
RECRUITING
START Midwest ( Site 0267), Grand Rapids
RECRUITING
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 0111), Siena
RECRUITING
MEDICAL COLLEGE OF WISCONSIN-Cancer Center Clinical Trials Office ( Site 0262), Milwaukee
RECRUITING
Communal Non-Commercial Enterprise Prykarpatski Clinical Onc-Chemotherapy department ( Site 0251), Ivano-Frankivsk
RECRUITING
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0110), Napoli
RECRUITING
Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 0445), Kaohsiung Niao Sung Dist
RECRUITING
Uzhhorod Multispecialty City Clinical Hospital ( Site 0258), Uzhhorod
RECRUITING
Sarawak General Hospital ( Site 0453), Kuching
RECRUITING
Beijing Friendship Hospital Affiliate of Capital University-Oncology ( Site 0417), Beijing
COMPLETED
Jilin Cancer Hospital-oncology department ( Site 0412), Changchun
RECRUITING
Shanghai Chest Hospital-Oncology department ( Site 0410), Shanghai
RECRUITING
Shanghai East Hospital ( Site 0416), Shanghai
RECRUITING
Zhejiang Cancer Hospital-Thoracic oncology ( Site 0411), Hangzhou
RECRUITING
Fujian Cancer Hospital ( Site 0419), Fuzhou
RECRUITING
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0418), Wuhan
RECRUITING
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 0413), Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center-Internal medicine ( Site 0415), Guangzhou
RECRUITING
Rambam Health Care Campus-Oncology ( Site 0090), Haifa
RECRUITING
Meir Medical Center. ( Site 0091), Kfar Saba
COMPLETED
James Lind Centro de Investigacion del Cancer ( Site 0043), Temuco
RECRUITING
Sheba Medical Center-ONCOLOGY ( Site 0093), Ramat Gan
RECRUITING
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0041), Santiago
RECRUITING
FALP-UIDO ( Site 0040), Santiago
RECRUITING
Bradfordhill ( Site 0042), Santiago
RECRUITING
Shaare Zedek Medical Center-Oncology ( Site 0092), Jerusalem
RECRUITING
Hadassah Medical Center-Oncology ( Site 0094), Jerusalem
RECRUITING
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0260), Hackensack
RECRUITING
Cross Cancer Institute ( Site 0033), Edmonton
RECRUITING
The Moncton Hospital ( Site 0037), Moncton
RECRUITING
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0030), Hamilton
RECRUITING
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 0036), Kingston
RECRUITING
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0032), Toronto
RECRUITING
National Cancer Center Hospital East ( Site 0404), Kashiwa
RECRUITING
Kanagawa Cancer Center ( Site 0402), Yokohama
RECRUITING
Shizuoka Cancer Center ( Site 0401), Nakatogari
RECRUITING
National Cancer Center Hospital ( Site 0403), Chuo-ku
RECRUITING
Cancer Institute Hospital of JFCR ( Site 0400), Koto
RECRUITING
Centro Oncologico de Panama ( Site 0160), Panama City
COMPLETED
Centro Hemato Oncológico Paitilla ( Site 0163), Panama City
RECRUITING
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 0172), Poznan
RECRUITING
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 0170), Warsaw
RECRUITING
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0171), Gdansk
RECRUITING
Oddzial Onkologii Klinicznej z Pododdzialem Chemioterapii Jednodniowej ( Site 0173), Koszalin
RECRUITING
Seoul National University Hospital ( Site 0191), Seoul
RECRUITING
Samsung Medical Center-Division of Hematology/Oncology ( Site 0193), Seoul
RECRUITING
Hospital Universitari Vall d'Hebron-Oncology ( Site 0212), Barcelona
RECRUITING
Hacettepe Universite Hastaneleri-oncology hospital ( Site 0234), Ankara
Merck Sharp & Dohme LLC
INDUSTRY